Marc Lamb, MD
Orthopaedic Surgery · Somers Point, NJNPI 1447273180
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,250 of the $2,793 with a category attached, or 80.6%. Synthes USA Products LLC accounts for 81.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $2,320 and has fallen 96.1% since, to $91 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NJ, where the typical reported total is $2,530.
Across 25 payments — averaging $111.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes USA Products LLC$2K
- Endo Pharmaceuticals Inc.$201
- Johnson & Johnson$99
- Axogen$64
- Orthofix Medical, Inc.$44
- Eclipse Technology Solutions Inc.$31
- plus $75 from 4 others
What the payments were for
- Consulting fees$2,25081%
- Food & beverage$45316%
- Education$903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes USA Products LLC | 3 | $2,279 |
| Endo Pharmaceuticals Inc. | 9 | $201 |
| Johnson & Johnson | 4 | $99 |
| Axogen | 2 | $64 |
| Orthofix Medical, Inc. | 2 | $44 |
| Eclipse Technology Solutions Inc. | 1 | $31 |
| Stryker | 1 | $30 |
| Spinal Elements, Inc. | 1 | $18 |
| Endo USA, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
How this compares
$2,793 in reported general payments places this provider in the 50th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 22 | $628 |
| Cefadroxil | 97 | $612 |
| Methylprednisolone | 99 | $493 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $182 |
| Meloxicam | 41 | $174 |
| Naproxen | 19 | $125 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $114 |
| Tramadol Hcl | 33 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Somers Point
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Gregg KleinParamus$1.5M
- David NazarianMarlton$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.